Pilot study: possible association of IL10 promoter polymorphisms with CRMO.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Autoinflammatory Bone Diseases.Balkan medical journal · 2025
   Review
2. Chronic Recurrent Multifocal Osteomyelitis (CRMO) and Juvenile Spondyloarthritis (JSpA): To What Extent Are They Related?Journal of clinical medicine · 2023
   Article
3. Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report.Frontiers in medicine · 2023
   Review
4. Analysis of the fecal and oral microbiota in chronic recurrent multifocal osteomyelitis.Arthritis research & therapy · 2022
   Article
5. Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO).Journal of translational autoimmunity · 2021
   Review
6. High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO).Pediatric rheumatology online journal · 2020
   Article
7. Chronic non-bacterial osteomyelitis in the jaw.Journal of the Korean Association of Oral and Maxillofacial Surgeons · 2019
   Review
8. Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach.Pediatric rheumatology online journal · 2017
   Review
9. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment.Current osteoporosis reports · 2017
   Review
10. An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.Paediatric drugs · 2017
    Review
11. Serum Interleukin-6 and CCL11/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis.Frontiers in pediatrics · 2017
    Article
12. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO).PloS one · 2017
    Article
13. Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO).Rheumatology international · 2016
    Article
14. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO).Pediatric rheumatology online journal · 2013
    Article
15. Chronic recurrent multifocal osteomyelitis.Journal of clinical immunology · 2013
    Review
16. Chronic nonbacterial osteomyelitis in a child with previous juvenile dermatomyositis.The Journal of rheumatology · 2013
    Article
17. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis.Current rheumatology reports · 2012
    Review
18. Update: Cytokine Dysregulation in Chronic Nonbacterial Osteomyelitis (CNO).International journal of rheumatology · 2012
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as